LONDON, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Spur Therapeutics today announced data from its Phase 1/2 GALILEO-1 trial of FLT201, an adeno-associated virus (AAV) gene therapy candidate for Gaucher ...

Spur expects to report additional data from the Phase 1/2 GALILEO-1 trial in the first half of 2025 and initiate a Phase 3 trial for FLT201 in adults with Gaucher disease type 1 in 2025.

LONDON, July 08, 2024 (GLOBE NEWSWIRE) -- Spur Therapeutics, formerly Freeline Therapeutics, today announced it has completed enrollment in the Phase 1/2 GALILEO-1 clinical trial of FLT201 ...

Bains Elementary School fifth graders role-played a trial between Galileo and the church to their class at Bains Elementary. Camille Burns and Sarah Fudge’s class was split, and each side came ...

IN presenting us with an English translation of Karl v, Gebler's “Galileo,” Mrs. Sturge has conferred an unquestionable boon on those who, without caring to pursue the subject in Continental ...